BioXcel Therapeutics (BTAI) Reports Q1 Loss of $1.08/sh
BioXcel Therapeutics (NASDAQ: BTAI) reported Q1 EPS of ($1.08), versus ($0.79) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.
BioXcel Therapeutics (NASDAQ: BTAI) reported Q1 EPS of ($1.08), versus ($0.79) reported last year.
For earnings history and earnings-related data on BioXcel Therapeutics (BTAI) click here.